Weiss Multi-Strategy Advisers LLC - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 76 filers reported holding IMMUNE DESIGN CORP in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Weiss Multi-Strategy Advisers LLC ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q3 2018$95,000
-24.0%
27,5000.0%0.00%0.0%
Q2 2018$125,000
-52.7%
27,500
-65.6%
0.00%
-62.5%
Q1 2018$264,000
-59.9%
80,000
-52.7%
0.01%
-52.9%
Q4 2017$659,000
+93.8%
169,034
+238.1%
0.02%
+30.8%
Q1 2017$340,000
-38.2%
50,000
-50.0%
0.01%
-51.9%
Q4 2016$550,000100,0000.03%
Other shareholders
IMMUNE DESIGN CORP shareholders Q4 2017
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 1,236,394$5,626,0008.66%
Versant Venture Management, LLC 2,208,210$10,047,356,0003.14%
EcoR1 Capital, LLC 4,437,600$20,191,0001.92%
BVF INC/IL 4,158,353$18,921,0001.85%
Abingworth LLP 352,300$1,621,0000.93%
DAFNA Capital Management LLC 328,500$1,495,0000.70%
Bain Capital Public Equity Management, LLC 1,221,368$5,557,0000.38%
Portolan Capital Management 444,875$2,024,0000.21%
Telemetry Investments, L.L.C. 113,500$516,0000.20%
C M BIDWELL & ASSOCIATES LTD 13,055$59,0000.06%
View complete list of IMMUNE DESIGN CORP shareholders